Best of the Year antibody discovery AI Tool

Actimo Labs offers ActiMap, an advanced AI-powered platform for precise and rapid epitope mapping. Designed for researchers in academia, pharma, and biotech, it accelerates antibody discovery and biotherapeutic design by predicting target interactions from protein sequences in minutes, significantly reducing costs and development timelines.

PipeBio is a specialized, cloud-based bioinformatics platform designed for antibody, TCR, and peptide discovery. It enables researchers to analyze, visualize, and manage large-scale sequence data, integrating seamlessly with functional assay results to accelerate biologics development. Acquired by Benchling, it offers an end-to-end solution for modern drug discovery.